Skip to main content

Table 1 Basic demographic data of patients with hepatocellular carcinoma of different BCLC stages

From: Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis

Variable

Total (N = 2316)

BCLC stage 0 (N = 66)

BCLC stage A (N = 865)

BCLC stage B (N = 575)

BCLC stage C (N = 810)

Male

1748 (75.5)

46 (69.7)

605 (69.6)

437 (76.0)

660 (81.5)

Age (years)

63 (19–99)

62 (23–85)

63 (28–92)

64 (30–91)

61 (19–99)

Smoking

949 (41.0)

28 (42.4)

316 (36.5)

232 (40.3)

373 (46.0)

Alcohol use

868 (37.5)

22 (33.3)

283 (32.7)

218 (37.9)

345 (42.6)

HBV positive

1658 (71.6)

44 (66.7)

599 (69.2)

414 (72.0)

601 (74.2)

HCV positive

696 (30.1)

14 (21.2)

253 (29.2)

172 (29.9)

257 (31.7)

Cirrhosis

1395 (60.2)

43 (65.2)

511 (59.1)

334 (58.1)

507 (62.6)

Child–Pugh class A

877 (37.9)

66 (100)

277 (32.0)

225 (39.1)

309 (38.1)

Tumor size (cm)

6.1 (1.0–27)

1.7 (1.0–2.0)

2.9 (1.0–5.0)

7.5 (1.2–21)

9.4 (1.2–27)

Tumor number

2.1 (1–11)

1 (1–1)

1.5 (1–3)

2.5 (1–11)

2.7 (1–11)

Treatment,

surgery

538 (23.2)

27 (40.9)

289 (33.4)

164 (28.5)

58 (7.2)

Mortality

1302 (56.2)

37 (56.9)

472 (54.6)

313 (54.4)

480 (59.3)

Median follow-up duration (months)

20 (0–96)

52 (8–96)

32 (1–96)

19 (0–84)

12 (0–79)

  1. BCLC stage: Barcelona clinic liver cancer; HBV: Hepatitis B virus; HCV: Hepatitis C virus; OS: Overall survival; Number (%); Mean (range)